Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2023-08-04 00:00:00 ET · period of report 2023-08-02 · accession 0001209191-23-044650 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-08-04 | 2023-08-02 | RXRX | Gibson Christopher | CEO, Dir | M - OptEx | $4.42 | +39.9K | 955.7K | +4% | +$176.4K |
| DM | 2023-08-04 | 2023-08-02 | RXRX | Gibson Christopher | CEO, Dir | S - Sale+OE | $13.04 | -65.0K | 894.8K | -7% | -$847.9K |
| DM | 2023-08-04 | 2023-08-02 | RXRX | Gibson Christopher | CEO, Dir | M - OptEx | $0.00 | -39.9K | 531.2K | -7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-08-02 | M | A | 8,674 | $11.40 | 924,484 | D | — | — | |
| 2 | Common | Class A Common Stock | 2023-08-02 | S | D | 4,060 | $13.36 | 890,719 | D | — | — | (F3) The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $13.35 to $13.43 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request |
| 3 | Common | Class A Common Stock | 2023-08-02 | S | D | 60,955 | $13.02 | 894,779 | D | — | — | (F2) The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $12.35 to $13.34 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request. |
| 4 | Common | Class A Common Stock | 2023-08-02 | M | A | 31,250 | $2.48 | 955,734 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2023-08-02 | M | D | 8,674 | $0.00 | 407,676 | D | $11.40 · — to 2032-02-04 | 8,674 Class A Common Stock | (F5) The option, originally for 416,350 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. |
| 6 | Derivative | Stock Option (Right to Buy) | 2023-08-02 | M | D | 31,250 | $0.00 | 531,250 | D | $2.48 · — to 2030-12-30 | 31,250 Class A Common Stock | (F6) The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter. |